Detailed Information for S00160

Basic information about inhibitors

IPAD-DB ID S00160
Name Zinc protoporphyrin IX
Category Synthetic compounds
2D Structure
3D Structure
Molecular Formula C 3 4 H 3 2 N 4 O 4 Z n
Molecular Weight 626.0 g/mol
IUPAC Name zinc;3-[18-(2-carboxyethyl)-7, 12-bis(ethenyl)-3, 8, 13, 17-tetramethylporphyrin-21, 23-diid-2-yl]propanoic acid
InChI InChI=1S/C34H34N4O4.Zn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8, 13-16H, 1-2, 9-12H2, 3-6H3, (H4, 35, 36, 37, 38, 39, 40, 41, 42);/q;+2/p-2
InChIKey FUTVBRXUIKZACV-UHFFFAOYSA-L
Canonical SMILES CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C=C)C)C=C)C)C(=C3CCC(=O)O)C)CCC(=O)O.[Zn+2]
PubChem CID 448842
DrugBank Accession Number -
CAS Registry Number -

Biological activity data

Ki -
EC50
IC50
Inhibition
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein Aβ1-40
Effects Inhibite the β-amyloid aggregation process.
Research Models In human IMR32 neuroblastoma cells
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 626.02
Hac(Computed by SwissADME) 43
Volume(Computed by ADMETlab 2.0) 590.802
Density(Computed by ADMETlab 2.0) 0.948
nRing(Computed by ADMETlab 2.0) 5
MaxRing(Computed by ADMETlab 2.0) 20
nHet(Computed by ADMETlab 2.0) 8
fChar(Computed by ADMETlab 2.0) -2
nRig(Computed by ADMETlab 2.0) 32
Flexibility(Computed by ADMETlab 2.0) 0.25
Stero Centers(Computed by ADMETlab 2.0) 0
LogS(Computed by ADMETlab 2.0) -2.942
LogD(Computed by ADMETlab 2.0) 3.26

ADMET properties

logP(Computed by ADMETlab 2.0) 6.298
TPSA(Computed by SwissADME) 125.1
Hbond Acceptor(Computed by SwissADME) 8
Hbond Donor(Computed by SwissADME) 2
Rotatable Bonds(Computed by SwissADME) 8

Pharmacokinetics

GI Absorption(Computed by SwissADME) High
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -6.83

Druglikeness

Lipinski(Computed by SwissADME) 1
Ghose(Computed by SwissADME) 3
Veber(Computed by SwissADME) 0
Egan(Computed by SwissADME) 0
Muegge(Computed by SwissADME) 1
Bioavailability Score(Computed by SwissADME) 0.56